Aster Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,985
Closed -$34.3K 1062
2025
Q1
$34.3K Buy
3,985
+3,836
+2,574% +$33K 0.01% 892
2024
Q4
$1.12K Sell
149
-3,489
-96% -$26.2K ﹤0.01% 1006
2024
Q3
$27.6K Buy
+3,638
New +$27.6K 0.01% 623